Today: 22 May 2026
Kulicke & Soffa stock price today: KLIC steadies premarket after 19% earnings jump, Needham lifts target
6 February 2026
2 mins read

Kulicke & Soffa stock price today: KLIC steadies premarket after 19% earnings jump, Needham lifts target

New York, Feb 6, 2026, 09:15 EST — Premarket.

  • KLIC edged up roughly 0.4% in premarket, following Thursday’s sharp 19.3% gain.
  • The chip-assembly tool maker expects second-quarter revenue around $230 million, with a $10 million margin on either side.
  • Needham’s Charles Shi bumped up his price target to $70 from $64, maintaining a “Buy” rating.

Kulicke and Soffa Industries, Inc. shares nudged higher by roughly 0.4% to $66.66 in premarket action Friday, building on a strong rally from the day before after the company issued a positive outlook.

The stock jumped 19.27% to close at $66.40 on Thursday, hitting close to the peak of its 52-week range. That rally pushed the $3.5 billion company back into focus for traders ahead of Friday’s session.

Why it matters now: Kulicke & Soffa provides gear for assembling and packaging chips, a segment that often rebounds fast once utilization picks up and clients scramble for capacity. The sharp one-day jump indicates investors are betting the slump in assembly tools is loosening, particularly in areas like memory and broad semiconductors.

Kulicke & Soffa reported fiscal Q1 net revenue of $199.6 million on Feb. 4, with a gross margin of 49.6%. Diluted GAAP earnings came in at $0.32 per share. The company projects Q2 revenue around $230 million, give or take $10 million, and non-GAAP diluted EPS near $0.67, plus or minus 10%. (Non-GAAP figures exclude items like stock-based compensation.) Interim CEO and CFO Lester Wong said, “As we continue preparing to support customers’ higher near-term capacity requirements, we remain committed to broadening our market reach in parallel.” https://investor.kns.com/2026-02-04-Kulick…

During Thursday’s earnings call, Wong highlighted that demand is picking up faster than anticipated, with utilization rates—how intensively customers use their installed tools—exceeding 80% in general semiconductors and surpassing 85% for ball bonding in memory. He reported a 27% jump in general semiconductor revenue from the previous quarter and a surge of over 90% compared to last year. The company also delivered its first high-bandwidth memory system to a major memory client this quarter. “We think the second half of FY ’26 should be about 15% to 20% better than the first half,” Wong added. https://www.insidermonkey.com/blog/kulicke…

On Friday, Needham analyst Charles Shi lifted his price target on Kulicke & Soffa from $64 to $70, maintaining a “Buy” rating, according to GuruFocus. https://www.gurufocus.com/news/8589524/nee…

On Thursday, the company filed its quarterly report on Form 10-Q with the U.S. Securities and Exchange Commission, covering the period ended Jan. 3. Investors are sifting through the details following a sharp shift in the stock’s valuation.

Kulicke & Soffa’s lineup features ball bonders and various assembly tools designed to link chips to packages. The company also offers newer thermocompression bonding systems, which apply heat and pressure to join components as packaging grows more intricate.

But the setup carries risks. Premarket trading tends to be thin, causing prices to swing sharply on low volume. Management also warned of ongoing weakness in the automotive segment. Plus, the company posted negative operating cash flow for the quarter, underscoring that a demand rebound doesn’t always translate immediately into cash.

On Friday, traders will be watching to see if KLIC can maintain most of Thursday’s gains once regular trading kicks off, and whether the chatter around utilization and memory demand actually leads to stronger orders. The next major test comes with execution against the company’s Q2 outlook, covering the period through April 4, 2026.

Stock Market Today

  • Q1 Earnings Review: Azenta Falls; West Pharmaceutical Leads Drug Development Services Stocks
    May 21, 2026, 9:31 PM EDT. Drug development inputs and services stocks, essential for pharmaceutical research and manufacturing, reported mixed Q1 results. Azenta (NASDAQ:AZTA), specializing in biological sample management, posted disappointing results with $144.8 million revenue, missing estimates and the weakest among peers, causing its share price to drop 23.4% to $17.65. Conversely, West Pharmaceutical Services (NYSE:WST), maker of specialized packaging and delivery devices, delivered a strong quarter with $844.9 million revenue, beating estimates by 8.4%. Overall, the sector's revenues beat consensus by 1.6%, despite an average 2.5% share price decline post-earnings. Tailwinds include growth in biologics and gene therapies, while headwinds feature pricing pressure and regulatory risks.

Latest articles

OpenAI Shares Hype Returns, Still No Ticker in Sight

OpenAI Shares Hype Returns, Still No Ticker in Sight

22 May 2026
OpenAI is preparing to confidentially file for a U.S. IPO, aiming to go public as early as September, sources told Reuters. The move follows a court win against Elon Musk, removing a key legal obstacle. Private-market share prices for OpenAI ranged from $658.94 to $732.38 this month, but no official public price exists. Ordinary investors still cannot buy OpenAI stock on public exchanges.
Estée Lauder Shares Gain as Rumored Deal Fails to Materialize

Estée Lauder Shares Gain as Rumored Deal Fails to Materialize

22 May 2026
Estée Lauder and Spain’s Puig ended merger talks that would have created a $40 billion beauty group. Estée Lauder shares rose about 10% in after-hours trading, closing the regular session at $78.91. The company said it will focus on its turnaround plan and continue reviewing possible acquisitions or divestitures.
WhiteFiber Stock Rips 22% on $160 Million AI Deal. The Test Comes in July

WhiteFiber Stock Rips 22% on $160 Million AI Deal. The Test Comes in July

22 May 2026
WhiteFiber shares jumped 22.2% to $29.55 after announcing a five-year AI compute contract worth over $160 million for a Paris-region deployment using NVIDIA GPU systems. Google Finance showed the stock rising further after hours. The project is backed by planned financing and 12 months of customer prepayments, but funding and execution remain pending. Service is expected to start in July, subject to equipment delivery and acceptance.
Google stock price slips as Alphabet’s AI spending push keeps GOOG in focus
Previous Story

Google stock price slips as Alphabet’s AI spending push keeps GOOG in focus

Robinhood stock jumps nearly 15% as bitcoin rebounds; earnings next week in focus
Next Story

Robinhood stock jumps nearly 15% as bitcoin rebounds; earnings next week in focus

Go toTop